A detailed history of Red Cedar Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Red Cedar Investment Management, LLC holds 35,927 shares of ABBV stock, worth $6.31 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
35,927
Previous 35,927 -0.0%
Holding current value
$6.31 Million
Previous $6.16 Million 15.12%
% of portfolio
0.9%
Previous 0.84%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $485,053 - $552,673
3,035 Added 9.23%
35,927 $6.54 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $41,145 - $47,632
308 Added 0.95%
32,892 $4.9 Million
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $1.52 Million - $1.75 Million
10,517 Added 47.66%
32,584 $5.19 Million
Q4 2022

Jan 26, 2023

BUY
$138.31 - $165.87 $215,072 - $257,927
1,555 Added 7.58%
22,067 $0
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $293,383 - $336,490
2,186 Added 11.93%
20,512 $2.75 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $566,168 - $719,785
-4,114 Reduced 18.33%
18,326 $2.81 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $390,000 - $483,881
2,955 Added 15.17%
22,440 $3.64 Million
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $348,247 - $395,312
3,273 Added 20.19%
19,485 $2.1 Million
Q2 2021

Aug 02, 2021

SELL
$105.21 - $117.21 $344,352 - $383,628
-3,273 Reduced 16.8%
16,212 $1.83 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $1.32 Million - $1.78 Million
16,399 Added 531.4%
19,485 $2.09 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $265,118 - $311,161
3,086 New
3,086 $270,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Red Cedar Investment Management, LLC Portfolio

Follow Red Cedar Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Cedar Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Cedar Investment Management, LLC with notifications on news.